FBRX
Forte Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$612.95M
P/E Ratio
—
EPS
$-4.71
Beta
3.20
52W High
$35.80
52W Low
$4.90
50-Day MA
$28.58
200-Day MA
$19.61
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Forte Biosciences Inc
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-70.59M |
| Operating Margin | 0.00% |
| Return on Equity | -122.30% |
| Return on Assets | -61.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.42 |
| Price-to-Book | 10.02 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $19.60M |
| Float | $15.68M |
| % Insiders | 2.36% |
| % Institutions | 67.17% |
Historical Volatility
HV 10-Day
158.50%
HV 20-Day
121.40%
HV 30-Day
103.64%
HV 60-Day
100.36%
HV Rank
42.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($63.75 target)
5
BuyData last updated: 4/16/2026